[{"data":1,"prerenderedAt":407},["ShallowReactive",2],{"$f8Pl_vlTgCTLyNBjB0G-kZv7PCHh_aTcsDaAtPaQPNJA":3},{"rows":4,"total":336,"page":21,"perPage":226,"facets":337,"applied":406},[5,25,42,55,68,81,96,111,130,140,158,174,189,200,212,229,240,256,268,279,294,302,315,328],{"slug":6,"name":7,"category":8,"aliases":9,"fdaApproved":13,"wadaBanned":13,"hasSequence":13,"molecularWeight":14,"administrationRoutes":15,"researchStatus":17,"researchSourceCount":18,"humanRctCount":19,"humanStudyCount":19,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":18,"research":20,"communityClaimCount":19,"communitySourceCount":19,"positiveReportCount":19,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":23,"alignment":24,"researchGap":13,"communityGap":13},"5-amino-1mq","5-Amino-1MQ","experimental",[7,10,11,12],"5-amino-1-methylquinolinium","NNMTi","NNMT inhibitor",false,159.21,[16],"Oral in the published rodent work","Preclinical research compound — no human trials published",2,0,{"mechanistic_confidence":21,"safety_characterization":22,"regulatory_maturity":18},1,3,{},"insufficient_data",{"slug":26,"name":27,"category":28,"aliases":29,"fdaApproved":13,"wadaBanned":34,"hasSequence":34,"molecularWeight":35,"administrationRoutes":36,"researchStatus":37,"researchSourceCount":38,"humanRctCount":19,"humanStudyCount":19,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":38,"research":39,"communityClaimCount":21,"communitySourceCount":21,"positiveReportCount":21,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":40,"alignment":41,"researchGap":34,"communityGap":13},"ace-031","ACE-031","muscle-growth-recovery",[30,31,32,33],"ACE-031 (development code)","ACVR2B-Fc","ActRIIB-Fc fusion protein","soluble activin receptor type IIB",true,null,[],"Clinical Trials",32,{"mechanistic_confidence":21,"regulatory_maturity":18},{"report_volume":21,"report_consistency":21,"source_diversity":21,"positive_effect_reports":21,"negative_effect_reports":19,"adverse_effect_reports":19,"lack_of_effect_reports":19,"reported_disagreement":19},"research_gap",{"slug":43,"name":44,"category":45,"aliases":46,"fdaApproved":13,"wadaBanned":13,"hasSequence":13,"molecularWeight":49,"administrationRoutes":50,"researchStatus":52,"researchSourceCount":22,"humanRctCount":19,"humanStudyCount":19,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":22,"research":53,"communityClaimCount":19,"communitySourceCount":19,"positiveReportCount":19,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":54,"alignment":24,"researchGap":13,"communityGap":13},"adalank","Adalank","cognitive-mental",[47,48],"Selank analog","Selank derivative",792.93,[51],"Injectable","Research compound - Not FDA-approved; approved for clinical use in Russia since early 2000s",{"mechanistic_confidence":21,"regulatory_maturity":18},{},{"slug":56,"name":57,"category":45,"aliases":58,"fdaApproved":13,"wadaBanned":13,"hasSequence":13,"molecularWeight":62,"administrationRoutes":63,"researchStatus":64,"researchSourceCount":22,"humanRctCount":19,"humanStudyCount":19,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":22,"research":65,"communityClaimCount":66,"communitySourceCount":19,"positiveReportCount":66,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":67,"alignment":41,"researchGap":34,"communityGap":13},"adamax","Adamax",[59,60,61],"Semax analog","adamantane-modified semax","N-phenylacetyl ACTH-derived peptide derivative",1032.24,[51],"Research compound - experimental peptide with limited human research data",{"mechanistic_confidence":21},7,{"report_volume":22,"report_consistency":21,"source_diversity":21,"positive_effect_reports":22,"negative_effect_reports":19,"adverse_effect_reports":19,"lack_of_effect_reports":19,"reported_disagreement":19},{"slug":69,"name":70,"category":8,"aliases":71,"fdaApproved":13,"wadaBanned":13,"hasSequence":34,"molecularWeight":76,"administrationRoutes":77,"researchStatus":78,"researchSourceCount":19,"humanRctCount":19,"humanStudyCount":19,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":19,"research":79,"communityClaimCount":19,"communitySourceCount":19,"positiveReportCount":19,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":80,"alignment":24,"researchGap":13,"communityGap":13},"adipotide","Adipotide",[70,72,73,74,75],"FTPP","fat-targeted proapoptotic peptide","CKGGRAKDC-GG-D(KLAKLAK)2","prohibitin-targeting peptide",2557.2,[],"Preclinical research peptide — development did not progress to approval",{"mechanistic_confidence":21,"safety_characterization":22,"regulatory_maturity":18},{},{"slug":82,"name":83,"category":84,"aliases":85,"fdaApproved":13,"wadaBanned":13,"hasSequence":34,"molecularWeight":90,"administrationRoutes":91,"researchStatus":93,"researchSourceCount":22,"humanRctCount":19,"humanStudyCount":19,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":18,"research":94,"communityClaimCount":19,"communitySourceCount":19,"positiveReportCount":19,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":95,"alignment":24,"researchGap":13,"communityGap":13},"ahk","AHK","skin-beauty",[83,86,87,88,89],"Ala-His-Lys","AHK-Cu","alanyl-histidyl-lysine","tripeptide-3",354.41,[92],"Topical","Cosmetic ingredient with ex vivo human hair follicle data",{"mechanistic_confidence":18,"safety_characterization":22,"regulatory_maturity":21},{},{"slug":97,"name":87,"category":84,"aliases":98,"fdaApproved":13,"wadaBanned":13,"hasSequence":13,"molecularWeight":103,"administrationRoutes":104,"researchStatus":105,"researchSourceCount":18,"humanRctCount":19,"humanStudyCount":19,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":18,"research":106,"communityClaimCount":107,"communitySourceCount":21,"positiveReportCount":108,"negativeReportCount":19,"adverseReportCount":108,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":109,"alignment":41,"researchGap":34,"communityGap":13},"ahk-cu",[99,100,101,102],"Alanyl-histidyl-lysine copper","Ala-His-Lys-Cu","AHK-Cu peptide","Copper tripeptide-3",900,[92],"Research compound - Copper tripeptide",{"mechanistic_confidence":21,"regulatory_maturity":21},12,6,{"report_volume":110,"report_consistency":21,"source_diversity":21,"positive_effect_reports":22,"negative_effect_reports":19,"adverse_effect_reports":22,"lack_of_effect_reports":19,"reported_disagreement":19},4,{"slug":112,"name":113,"category":114,"aliases":115,"fdaApproved":13,"wadaBanned":34,"hasSequence":34,"molecularWeight":120,"administrationRoutes":121,"researchStatus":124,"researchSourceCount":125,"humanRctCount":19,"humanStudyCount":19,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":126,"research":127,"communityClaimCount":128,"communitySourceCount":21,"positiveReportCount":108,"negativeReportCount":19,"adverseReportCount":110,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":129,"alignment":41,"researchGap":34,"communityGap":13},"aicar","AICAR","performance-enhancement",[113,116,117,118,119],"Acadesine","5-Aminoimidazole-4-carboxamide ribonucleoside","AICA riboside","AICA-riboside",258.23,[122,123],"IV","SC","Research compound - AMPK activator",29,28,{"mechanistic_confidence":18},10,{"report_volume":110,"report_consistency":21,"source_diversity":21,"positive_effect_reports":22,"negative_effect_reports":19,"adverse_effect_reports":22,"lack_of_effect_reports":19,"reported_disagreement":19},{"slug":131,"name":132,"category":28,"aliases":133,"fdaApproved":13,"wadaBanned":13,"hasSequence":13,"molecularWeight":35,"administrationRoutes":136,"researchStatus":137,"researchSourceCount":19,"humanRctCount":19,"humanStudyCount":19,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":19,"research":138,"communityClaimCount":19,"communitySourceCount":19,"positiveReportCount":19,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":139,"alignment":24,"researchGap":13,"communityGap":13},"aod-9604-cjc-1295-ipamorelin-blend","AOD-9604 + CJC-1295 + Ipamorelin Blend",[134,135],"AOD-9604 + CJC-1295 + Ipamorelin","AOD/CJC/Ipa blend",[],"Compounded blend — no studies of the combination",{"mechanistic_confidence":21,"safety_characterization":22},{},{"slug":141,"name":142,"category":8,"aliases":143,"fdaApproved":13,"wadaBanned":13,"hasSequence":34,"molecularWeight":148,"administrationRoutes":149,"researchStatus":150,"researchSourceCount":151,"humanRctCount":19,"humanStudyCount":21,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":152,"research":153,"communityClaimCount":155,"communitySourceCount":21,"positiveReportCount":154,"negativeReportCount":19,"adverseReportCount":22,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":156,"alignment":157,"researchGap":13,"communityGap":13},"aod9604","AOD9604",[144,145,146,147],"AOD-9604","hGH fragment 177-191","modified human growth hormone C-terminal fragment","AOD9604 hexadecapeptide",1815.12,[123],"Research compound - HGH fragment",19,17,{"human_other_evidence":18,"mechanistic_confidence":22,"safety_characterization":22,"replication":18,"recency":154},5,8,{"report_volume":22,"report_consistency":21,"source_diversity":21,"positive_effect_reports":22,"negative_effect_reports":19,"adverse_effect_reports":18,"lack_of_effect_reports":19,"reported_disagreement":19},"aligned",{"slug":159,"name":160,"category":45,"aliases":161,"fdaApproved":13,"wadaBanned":13,"hasSequence":34,"molecularWeight":166,"administrationRoutes":167,"researchStatus":168,"researchSourceCount":169,"humanRctCount":21,"humanStudyCount":19,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":170,"research":171,"communityClaimCount":172,"communitySourceCount":21,"positiveReportCount":107,"negativeReportCount":19,"adverseReportCount":22,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":173,"alignment":157,"researchGap":13,"communityGap":13},"ara-290","ARA-290",[162,163,164,165],"Cibinetide","ARA 290","ARA290","EPO-derived peptide",2900,[123],"Research compound - EPO derivative",48,47,{"human_rct_evidence":18,"mechanistic_confidence":22,"safety_characterization":18,"regulatory_maturity":21,"replication":18,"recency":154},15,{"report_volume":110,"report_consistency":21,"source_diversity":21,"positive_effect_reports":110,"negative_effect_reports":19,"adverse_effect_reports":18,"lack_of_effect_reports":19,"reported_disagreement":19},{"slug":175,"name":176,"category":84,"aliases":177,"fdaApproved":13,"wadaBanned":13,"hasSequence":34,"molecularWeight":183,"administrationRoutes":184,"researchStatus":185,"researchSourceCount":186,"humanRctCount":19,"humanStudyCount":19,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":186,"research":187,"communityClaimCount":155,"communitySourceCount":21,"positiveReportCount":154,"negativeReportCount":19,"adverseReportCount":22,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":188,"alignment":41,"researchGap":34,"communityGap":13},"argireline","Argireline",[178,179,180,181,182],"Acetyl Hexapeptide-8","Acetyl Hexapeptide-3","AH-8","Ac-Glu-Glu-Met-Gln-Arg-Arg-NH2","Argireline acetate",888.05,[92],"Cosmetic ingredient - Hexapeptide",23,{"mechanistic_confidence":21,"safety_characterization":22},{"report_volume":22,"report_consistency":21,"source_diversity":21,"positive_effect_reports":22,"negative_effect_reports":19,"adverse_effect_reports":18,"lack_of_effect_reports":19,"reported_disagreement":19},{"slug":190,"name":191,"category":8,"aliases":192,"fdaApproved":13,"wadaBanned":13,"hasSequence":13,"molecularWeight":35,"administrationRoutes":195,"researchStatus":197,"researchSourceCount":110,"humanRctCount":19,"humanStudyCount":19,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":110,"research":198,"communityClaimCount":19,"communitySourceCount":19,"positiveReportCount":19,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":199,"alignment":24,"researchGap":13,"communityGap":13},"b7-33","B7-33",[191,193,194],"relaxin B-chain peptidomimetic","single-chain relaxin-2 analogue",[196],"Intravenous","Preclinical research peptide — no human trials published",{"mechanistic_confidence":21,"safety_characterization":22,"regulatory_maturity":18},{},{"slug":201,"name":202,"category":8,"aliases":203,"fdaApproved":13,"wadaBanned":13,"hasSequence":13,"molecularWeight":35,"administrationRoutes":207,"researchStatus":209,"researchSourceCount":22,"humanRctCount":19,"humanStudyCount":19,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":22,"research":210,"communityClaimCount":19,"communitySourceCount":19,"positiveReportCount":19,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":211,"alignment":24,"researchGap":13,"communityGap":13},"bioglutide","Bioglutide",[204,205,206],"NA-931","Bioglutide (research product name)","quadruple receptor agonist NA-931",[208],"Oral","Investigational drug - not yet FDA approved; Phase 2b/3 trials for obesity and type 2 diabetes",{"mechanistic_confidence":21,"regulatory_maturity":18},{},{"slug":213,"name":214,"category":28,"aliases":215,"fdaApproved":13,"wadaBanned":34,"hasSequence":34,"molecularWeight":221,"administrationRoutes":222,"researchStatus":223,"researchSourceCount":224,"humanRctCount":19,"humanStudyCount":19,"animalCount":18,"inVitroCount":19,"unclassifiedSourceCount":170,"research":225,"communityClaimCount":226,"communitySourceCount":154,"positiveReportCount":172,"negativeReportCount":19,"adverseReportCount":227,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":228,"alignment":157,"researchGap":13,"communityGap":13},"bpc-157","BPC-157",[216,217,218,219,220],"BPC 157","Body Protection Compound-157","Stable gastric pentadecapeptide BPC 157","Pentadecapeptide BPC 157","PL 14736",1419.53,[123,208],"Investigational - Not approved for human use",53,{"animal_evidence":22,"mechanistic_confidence":22,"safety_characterization":154,"regulatory_maturity":21,"replication":22,"recency":110},24,9,{"report_volume":154,"report_consistency":18,"source_diversity":22,"positive_effect_reports":110,"negative_effect_reports":19,"adverse_effect_reports":110,"lack_of_effect_reports":19,"reported_disagreement":19},{"slug":230,"name":231,"category":232,"aliases":233,"fdaApproved":13,"wadaBanned":13,"hasSequence":13,"molecularWeight":35,"administrationRoutes":237,"researchStatus":137,"researchSourceCount":19,"humanRctCount":19,"humanStudyCount":19,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":19,"research":238,"communityClaimCount":19,"communitySourceCount":19,"positiveReportCount":19,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":239,"alignment":24,"researchGap":13,"communityGap":13},"bpc-157-tb-500-blend","BPC-157 + TB-500 Blend","pain-management",[234,235,236],"BPC-157 + TB-500","BPC/TB blend","repair blend",[],{"mechanistic_confidence":21,"safety_characterization":22},{},{"slug":241,"name":242,"category":243,"aliases":244,"fdaApproved":13,"wadaBanned":13,"hasSequence":34,"molecularWeight":248,"administrationRoutes":249,"researchStatus":252,"researchSourceCount":22,"humanRctCount":19,"humanStudyCount":21,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":18,"research":253,"communityClaimCount":19,"communitySourceCount":19,"positiveReportCount":19,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":254,"alignment":255,"researchGap":13,"communityGap":34},"bronchogen","Bronchogen","wellness-recovery",[242,245,246,247],"Ala-Glu-Asp-Leu","AEDL","AEDL peptide",446.5,[250,251],"Subcutaneous","intramuscular in the source literature","Research compound — short peptide bioregulator",{"human_other_evidence":18,"mechanistic_confidence":22,"safety_characterization":22,"regulatory_maturity":21,"replication":18,"recency":110},{},"community_gap",{"slug":257,"name":258,"category":8,"aliases":259,"fdaApproved":13,"wadaBanned":13,"hasSequence":13,"molecularWeight":263,"administrationRoutes":264,"researchStatus":265,"researchSourceCount":154,"humanRctCount":19,"humanStudyCount":18,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":22,"research":266,"communityClaimCount":19,"communitySourceCount":19,"positiveReportCount":19,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":267,"alignment":255,"researchGap":13,"communityGap":34},"cagrilintide","Cagrilintide",[260,261,262],"amylin analogue","long-acting amylin receptor agonist","CagriSema (co-administered with semaglutide)",4409.01,[51],"Investigational - FDA development candidate with Phase 3 data; FDA approval expected Q1 2026",{"human_other_evidence":22,"mechanistic_confidence":22,"regulatory_maturity":18,"replication":22,"recency":154},{},{"slug":269,"name":270,"category":8,"aliases":271,"fdaApproved":13,"wadaBanned":13,"hasSequence":13,"molecularWeight":35,"administrationRoutes":275,"researchStatus":276,"researchSourceCount":110,"humanRctCount":18,"humanStudyCount":18,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":19,"research":277,"communityClaimCount":19,"communitySourceCount":19,"positiveReportCount":19,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":278,"alignment":255,"researchGap":13,"communityGap":34},"cagrilintide-semaglutide-blend","Cagrilintide + Semaglutide (CagriSema)",[272,273,274],"CagriSema","cagrilintide-semaglutide","cagrilintide + semaglutide",[],"Phase 3 investigational combination — not approved",{"human_rct_evidence":22,"human_other_evidence":22,"mechanistic_confidence":110,"safety_characterization":22,"regulatory_maturity":18,"replication":22,"recency":154},{},{"slug":280,"name":281,"category":114,"aliases":282,"fdaApproved":13,"wadaBanned":34,"hasSequence":13,"molecularWeight":287,"administrationRoutes":288,"researchStatus":289,"researchSourceCount":290,"humanRctCount":19,"humanStudyCount":19,"animalCount":21,"inVitroCount":19,"unclassifiedSourceCount":291,"research":292,"communityClaimCount":128,"communitySourceCount":21,"positiveReportCount":108,"negativeReportCount":19,"adverseReportCount":110,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":293,"alignment":157,"researchGap":13,"communityGap":13},"cardarine","Cardarine (GW501516)",[283,284,285,286],"GW501516","GW-501516","GSK-516","Endurobol",453.5,[208],"Research compound - PPAR-delta agonist",39,37,{"animal_evidence":18,"mechanistic_confidence":22,"safety_characterization":22,"regulatory_maturity":21,"replication":18,"recency":21},{"report_volume":110,"report_consistency":21,"source_diversity":21,"positive_effect_reports":22,"negative_effect_reports":19,"adverse_effect_reports":22,"lack_of_effect_reports":19,"reported_disagreement":19},{"slug":295,"name":296,"category":243,"aliases":297,"fdaApproved":13,"wadaBanned":13,"hasSequence":13,"molecularWeight":35,"administrationRoutes":298,"researchStatus":299,"researchSourceCount":21,"humanRctCount":19,"humanStudyCount":21,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":19,"research":300,"communityClaimCount":19,"communitySourceCount":19,"positiveReportCount":19,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":301,"alignment":255,"researchGap":13,"communityGap":34},"cardiogen","Cardiogen",[296],[],"Research compound — no indexed literature located",{"human_other_evidence":18,"mechanistic_confidence":22,"safety_characterization":22,"replication":18,"recency":110},{},{"slug":303,"name":304,"category":243,"aliases":305,"fdaApproved":13,"wadaBanned":13,"hasSequence":13,"molecularWeight":35,"administrationRoutes":311,"researchStatus":312,"researchSourceCount":22,"humanRctCount":19,"humanStudyCount":19,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":22,"research":313,"communityClaimCount":19,"communitySourceCount":19,"positiveReportCount":19,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":314,"alignment":24,"researchGap":13,"communityGap":13},"cartalax","Cartalax",[306,307,308,309,310],"AED peptide","T-31","Ala-Glu-Asp tripeptide","Alanine-Glutamate-Aspartate","Khavinson bioregulator peptide",[208],"Research compound - Khavinson bioregulator with Russian clinical use; not FDA approved",{"mechanistic_confidence":21,"regulatory_maturity":18},{},{"slug":316,"name":317,"category":318,"aliases":319,"fdaApproved":13,"wadaBanned":13,"hasSequence":13,"molecularWeight":323,"administrationRoutes":324,"researchStatus":325,"researchSourceCount":186,"humanRctCount":21,"humanStudyCount":22,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":151,"research":326,"communityClaimCount":128,"communitySourceCount":21,"positiveReportCount":108,"negativeReportCount":19,"adverseReportCount":110,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":327,"alignment":157,"researchGap":13,"communityGap":13},"cerebrolysin","Cerebrolysin","sexual-wellness",[317,320,321,322],"FPE-1071","porcine brain-derived peptide preparation","cerebrolysin (brain peptide preparation)",2000,[122],"Prescription medication in some countries",{"human_rct_evidence":18,"human_other_evidence":22,"mechanistic_confidence":110,"safety_characterization":22,"replication":110,"recency":110},{"report_volume":110,"report_consistency":21,"source_diversity":21,"positive_effect_reports":22,"negative_effect_reports":19,"adverse_effect_reports":22,"lack_of_effect_reports":19,"reported_disagreement":19},{"slug":329,"name":330,"category":243,"aliases":331,"fdaApproved":13,"wadaBanned":13,"hasSequence":13,"molecularWeight":35,"administrationRoutes":333,"researchStatus":252,"researchSourceCount":22,"humanRctCount":19,"humanStudyCount":21,"animalCount":19,"inVitroCount":19,"unclassifiedSourceCount":18,"research":334,"communityClaimCount":19,"communitySourceCount":19,"positiveReportCount":19,"negativeReportCount":19,"adverseReportCount":19,"lackOfEffectReportCount":19,"contestedThemeCount":19,"community":335,"alignment":255,"researchGap":13,"communityGap":34},"chonluten","Chonluten",[330,332],"Chonluten tripeptide",[250,251],{"human_other_evidence":18,"mechanistic_confidence":22,"safety_characterization":22,"replication":18,"recency":110},{},124,{"category":338,"alignment":352,"administrationRoute":363},[339,341,343,344,345,346,348,350,351],{"value":8,"count":340},20,{"value":28,"count":342},18,{"value":84,"count":152},{"value":45,"count":172},{"value":243,"count":172},{"value":318,"count":347},14,{"value":349,"count":107},"anti-aging",{"value":114,"count":128},{"value":232,"count":22},[353,355,357,359,361],{"value":41,"count":354},35,{"value":24,"count":356},33,{"value":157,"count":358},30,{"value":255,"count":360},13,{"value":362,"count":360},"conflicting",[364,366,367,368,369,370,371,372,374,376,378,380,382,384,386,388,390,391,393,395,396,398,400,402,404],{"value":123,"count":365},44,{"value":208,"count":152},{"value":92,"count":152},{"value":250,"count":128},{"value":251,"count":227},{"value":51,"count":155},{"value":122,"count":155},{"value":373,"count":108},"Intranasal",{"value":375,"count":154},"IM",{"value":377,"count":21},"clinician-administered",{"value":379,"count":21},"clinician-supervised",{"value":381,"count":21},"Gene therapy",{"value":383,"count":21},"IM (local)",{"value":385,"count":21},"Injection in the published murine work",{"value":387,"count":21},"Intramuscular",{"value":389,"count":21},"intramuscular injection",{"value":196,"count":21},{"value":392,"count":21},"Nasal",{"value":394,"count":21},"Not established for human use",{"value":16,"count":21},{"value":397,"count":21},"Oral in the published work",{"value":399,"count":21},"parenteral in preclinical work",{"value":401,"count":21},"SC (local injection)",{"value":403,"count":21},"SC (localized)",{"value":405,"count":21},"subcutaneous depot injection",{},1793850664867]